Navigation Links
NanoFUSE Biologics Names Renowned Surgeon Dr. Darren Lebl to Its Growing Scientific Advisory Board
Date:12/31/2019

NanoFUSE Biologics is pleased to announce the addition of Dr. Darren Lebl to its Scientific Advisory Board. NanoFUSE Biologics offers a biologically enhanced synthetic therapeutic, which is the only FDA-cleared bioactive glass and demineralized bone matrix (DBM) combined medical device.

President of NanoFUSE Biologics, Jake Lubinski, said, “We’re fortunate to have a NanoFUSE Scientific Advisory Board of the best spine and orthopedic surgeons who are at the forefront of biologics use. Dr. Lebl brings a wealth of prestigious and extensive experience with biologics and how those biologics are used to best care for patients. We are privileged to welcome Dr. Lebl as the latest member to our team.”

Dr Lebl noted, “I am honored to be part of the Scientific Advisory Board for NanoFUSE. Spine surgery continues to evolve toward less invasive techniques that require surgeons to have the latest in biologic technology like NanoFUSE to help us achieve fusion with consistently successful results”

Dr. Darren Lebl is an Associate Professor of spinal surgery specializing in minimally invasive surgery, the cervical spine, motion preserving spine procedures, and robotic computer guided navigation surgery. His practice at Hospital for Special Surgery in New York City involves a customized approach to each individual patient to help maximize quality of life and musculoskeletal health. He incorporates innovative procedures, newer and less invasive surgical techniques, and biologics into his practice
.
After obtaining a triple major in biochemistry & molecular biology, chemistry, and economics at The University of Chicago Dr. Lebl received his MD degree from Stanford. He completed his orthopedic residency at Harvard, a spine surgery fellowship at The Hospital for Special Surgery in New York City, and an MBA from Wharton. He pursued additional advanced spine surgery training in cervical spine disorders, occipitocervical disorders, and spinal deformity surgery with international leaders in the USA, China, Japan, Spain, and Germany.

About NanoFUSE Biologics

NanoFUSE is a biologically enhanced synthetic therapeutic that combines osteoinductive DBM with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in general orthopedic applications. NanoFUSE Biologics is a KICVentures portfolio company and is distributed by SpineFrontier.

About KICVentures

KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed, NanoFUSE and SpineFrontier. It has headquarters in Boston, MA.

About Dr Darren Lebl

Dr. Lebl was the Editor-in-Chief of the Orthopedic Journal at Harvard Medical School and Academic Chief Resident at the Massachusetts General Hospital. He was later recognized as an “emerging leader” by the world’s oldest and most distinguished orthopedic association, the American Orthopedic Association, for his contributions to education and research. He has authored numerous peer-reviewed articles and book chapters on complication avoidance in spinal surgery, cervical spine disorders, minimally invasive procedures, and motion preserving spine procedures. Dr. Lebl was the director of both the Complex Cervical Spine Symposium and the Cervical Spine Motion Preservation Symposium at HSS. Dr. Lebl is a Fellow of the American Academy of Orthopedic Surgeons and an active member of distinguished societies such as the Cervical Spine Research Society, the North American Spine Society, and the Scoliosis Research Society.

Read the full story at https://www.prweb.com/releases/nanofuse_biologics_names_renowned_surgeon_dr_darren_lebl_to_its_growing_scientific_advisory_board/prweb16808791.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology
2. Biosimilars And Follow-On Biologics: World Market 2013-2023
3. Original Drugs Pave the Way for Follow-on Biologics
4. Synthetic Biologics to Host Multiple Sclerosis-Estriol Investor Day in New York City on June 25, 2013
5. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
6. For Moderate to Severe Psoriasis, Thought Leaders Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
7. Water Street Completes Investment in RTI Biologics Inc.
8. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
9. Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
10. Oncobiologics and inVentiv Health Form Strategic Partnership around Biosimilars
11. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... and FT. LAUDERDALE, Fla. (PRWEB) , ... February 14, 2020 , ... ... area, has joined the esteemed Haute Beauty Network. , The Haute Beauty Network, well ... Dr. Ray Lopez as a foot and ankle and our newest addition to the ...
(Date:2/14/2020)... ... February 14, 2020 , ... Dignitana AB , world leader in ... signed on to sponsor three signature events in 2020 with Susan G. Komen®. The ... Komen Race for the Cure® and MORE THAN PINK Walk® events in key Dignitana ...
(Date:2/14/2020)... FALLS CHURCH, Va. (PRWEB) , ... February 14, ... ... Imports, of Pharmaceuticals, Biologics and Medical Devices, An FDAnews Webinar , Tuesday, Feb. ... latest on importation issues with pharmaceuticals and medical devices? If one does not ...
Breaking Medicine Technology:
(Date:2/10/2020)... ... ... About That’s Sweet Trail Mix is a blend of keto approved nuts, unsweetened coconut and ... grams of protein and 3 grams of net carbs with zero added sugars. Unlike most ... the cleanest keto trail mix on the market. , The trail mix consists of only ...
(Date:2/10/2020)... ... 10, 2020 , ... “We're able to put our patients ... “laughing-gas”," says Dr. Crutchfield. "The patients are entirely present; however, pain, anxiety, and ... a new tool to help patients feel relaxed and comfortable during skin procedures. ...
(Date:2/10/2020)... ... 2020 , ... Explored Wellness has launched a website, ... healthier, and happier life through being well in all areas of life. ... including intellectual, physical, emotional, spiritual, and social wellness; and addresses the less-explored financial, ...
(Date:2/8/2020)... ... 2020 , ... Lerner and Rowe Injury Attorneys is pleased to once ... On February 15, 2020 guests will be transported to an exotic locale as the ... cocktail reception kicks off the festivities at 6:00 p.m. to be followed by a ...
(Date:2/8/2020)... ... February 08, 2020 , ... ... Ph.D., and Beverly Mock, Ph.D. in a scientifically-advanced webinar initiated by the National ... with the NCI (National Cancer Institute), where his research involves using synthetic chemistry ...
Breaking Medicine News(10 mins):